Further investigations to determine: (i) if FFAR2 or FFAR3 signalling is altered in the monocytes of colitis patients, and (ii) whether this abnormality is involved in disease pathology– may reveal novel insights on colitis and its treatment. This evidence concerns the gene FFAR3 and colitis.